Cargando…

Immunotherapy – 2076. A controlled study of delta inulin-adjuvanted honey bee venom immunotherapy

Detalles Bibliográficos
Autores principales:	Heddle, Robert, Russo, Paul, Petrovsky, Nikolai, Hanna, Rory, Smith, Anthony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization 2013
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643492/ http://dx.doi.org/10.1186/1939-4551-6-S1-P158

Ejemplares similares

Randomized controlled trial demonstrating the benefits of delta inulin adjuvanted immunotherapy in patients with bee venom allergy
por: Heddle, Robert, et al.
Publicado: (2019)

Pharmaceutical and preclinical evaluation of Advax adjuvant as a dose-sparing strategy for ant venom immunotherapy
por: Wanandy, Troy, et al.
Publicado: (2019)

Single venom-based immunotherapy effectively protects patients with double positive tests to honey bee and Vespula venom
por: Stoevesandt, Johanna, et al.
Publicado: (2013)

Advax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety
por: Petrovsky, Nikolai, et al.
Publicado: (2015)

Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single–dose influenza vaccine protection
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2015)

Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant
por: McPherson, Clifton, et al.
Publicado: (2015)

Intrapulmonary vaccination with delta-inulin adjuvant stimulates non-polarised chemotactic signalling and diverse cellular interaction
por: Ferrell, Kia C., et al.
Publicado: (2021)

Delta inulin-based adjuvants promote the generation of polyfunctional CD4(+) T cell responses and protection against Mycobacterium tuberculosis infection
por: Counoupas, Claudio, et al.
Publicado: (2017)

Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant
por: Gordon, David L., et al.
Publicado: (2016)

Combination of omalizumab and bee venom immunotherapy: does it work?
por: Yılmaz, İnsu, et al.
Publicado: (2018)

Advax, a Delta Inulin Microparticle, Potentiates In-built Adjuvant Property of Co-administered Vaccines
por: Hayashi, Masayuki, et al.
Publicado: (2016)

Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals
por: Bielefeldt-Ohmann, Helle, et al.
Publicado: (2014)

Simultaneous up‐dosing of bee and vespid venom immunotherapy is safe
por: Čerpes, Urban, et al.
Publicado: (2019)

Delta Inulin Adjuvant Enhances Plasmablast Generation, Expression of Activation-Induced Cytidine Deaminase and B-Cell Affinity Maturation in Human Subjects Receiving Seasonal Influenza Vaccine
por: Li, Lei, et al.
Publicado: (2015)

Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2017)

Effect of honey bee venom on differentiation of cholinergic neurons
por: Kouchesfahani, Homa Mohseni, et al.
Publicado: (2010)

Pharmacological properties and therapeutic potential of honey bee venom
por: Ullah, Amjad, et al.
Publicado: (2023)

Chemical Composition and Antimicrobial Properties of Honey Bee Venom
por: Isidorov, Valery, et al.
Publicado: (2023)

Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings?
por: Sahiner, Umit Murat, et al.
Publicado: (2019)

The prevalence of Api m 10 sensitization and the modification of immunotherapy in bee venom allergy
por: Górska, Aleksandra, et al.
Publicado: (2021)

Component-Resolved Evaluation of the Risk and Success of Immunotherapy in Bee Venom Allergic Patients
por: Rosiek-Biegus, Marta, et al.
Publicado: (2022)

Comparative Study of Antimicrobial Properties of Bee Venom Extracts and Melittins of Honey Bees
por: Maitip, Jakkrawut, et al.
Publicado: (2021)

Advax Adjuvant: A Potent and Safe Immunopotentiator Composed of Delta Inulin
por: Petroski, N.
Publicado: (2017)

Venom immunotherapy and pregnancy
por: Pałgan, Krzysztof, et al.
Publicado: (2018)

Honey bee venom re-challenge during specific immunotherapy: prolonged cardio-pulmonary resuscitation allowed survival in a case of near fatal anaphylaxis
por: Micaletto, Sara, et al.
Publicado: (2022)

466 Bee venom Immunotherapy with Standardized Extract, Two Case Comunication and Clinical Progress
por: Cardona, Aristoteles Alvarez, et al.
Publicado: (2012)

Doxorubicin-Loaded Delta Inulin Conjugates for Controlled and Targeted Drug Delivery: Development, Characterization, and In Vitro Evaluation
por: Wang, Lixin, et al.
Publicado: (2019)

Anti-PD-1 Immunotherapy and Bee Venom for Relapsed and Refractory Liposarcoma: A Case Report
por: Yang, Wei, et al.
Publicado: (2021)

Venom Immunotherapy and Aeroallergen Immunotherapy: How Do Their Outcomes Differ?
por: Incorvaia, Cristoforo, et al.
Publicado: (2022)

Mucosal immunization with a delta-inulin adjuvanted recombinant spike vaccine elicits lung-resident immune memory and protects mice against SARS-CoV-2
por: Stewart, Erica L., et al.
Publicado: (2022)

Chemical Profiling and Antimicrobial Properties of Honey Bee (Apis mellifera L.) Venom
por: Tanuwidjaja, Irina, et al.
Publicado: (2021)

Influence of Oxidation Degree on the Physicochemical Properties of Oxidized Inulin
por: Afinjuomo, Franklin, et al.
Publicado: (2020)

Allergen immunotherapy
por: Crisafulli, Giuseppe, et al.
Publicado: (2014)

Learning Impairment in Honey Bees Caused by Agricultural Spray Adjuvants
por: Ciarlo, Timothy J., et al.
Publicado: (2012)

Survey on practice of venom immunotherapy in France
por: Dzviga, Charles, et al.
Publicado: (2016)

Updates and Recent Advances on Venom Immunotherapy
por: Floyd, Michelle L., et al.
Publicado: (2023)

Investigation of honey bee venom effect on the immunogenicity of foot-and-mouth disease vaccine in sheep
por: Eweis, Asmaa R. F., et al.
Publicado: (2022)

Effect of honey bee venom on the histological changes of testes and hormonal disturbance in diabetic mice
por: AL-Shaeli, Sattar J. J., et al.
Publicado: (2022)

Cancer immunity and immunotherapy beyond COVID-19
por: Bellone, Matteo, et al.
Publicado: (2023)

Immunotherapy – 2071. Strail levels decreased after allergen-subcutaneous specific immunotherapy
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_c21egmm1q9q1k7lf0a4ebatrm8